Skip to content

A clinical trial to compare the effect of Timolol solution and normal saline in the treatment of foot ulcers in diabetic patients

Efficacy of topical Timolol versus normal saline in the treatment of diabetic foot ulcer: A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107158
Enrollment
80
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Timolol maleate: 1 drop of 0.5% Timolol maleate will be instilled every 2cm square of wound area, repeated every alternate day for totally 8 weeks. Control Intervention1: Normal Saline:

Sponsors

Dr Akshay P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known case of type 2 diabetes mellitus with diabetic foot ulcer- Grade 1 and 2 according to Wagner classification for more than 2 weeks.

Exclusion criteria

Exclusion criteria: Patients with history of coronary artery disease, cerebrovascular accident, peripheral arterial disease, COPD, venous obstruction, osteomyelitis and skin malignancies will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Assessment of percentage reduction in diabetic foot ulcer area since beginning of the study till 8th week.Timepoint: Assessment of percentage reduction in diabetic foot ulcer area since beginning of the study till 8th week.

Secondary

MeasureTime frame
To assess the area of ulcer (mm square), granulation tissue formation, occurrence of slough, percentage reduction in ulcer area (mm square). Assessing these points every 2nd, 4th and 8th week. To assess any localized adverse effects of Timolol maleate at 2nd, 4th and 8th week.Timepoint: 2nd, 4th and 8th week.

Countries

India

Contacts

Public ContactDr Akshay P

Sri Ramachandra Institute of Higher Education & Research (DU)

drsuru@yahoo.com9840230306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026